EP1569646 - PIPERIDINE DERIVATIVES AS CCR5 ANTAGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.09.2010 Database last updated on 24.08.2024 | Most recent event Tooltip | 17.09.2010 | Application deemed to be withdrawn | published on 20.10.2010 [2010/42] | Applicant(s) | For all designated states GlaxoSmithKline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | [N/P] |
Former [2010/09] | For all designated states GlaxoSmithKline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | ||
Former [2005/36] | For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia, PA 19102 / US | Inventor(s) | 01 /
KAZMIERSKI, Wieslaw Mieczyslaw GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Par, NC 27709 / US | 02 /
AQUINO, Christopher Joseph GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 03 /
BIFULCO, Neil GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 04 /
BOROS, Eric Eugene GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 05 /
CHAUDER, Brian Andrew GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 06 /
CHONG, Pek Yoke GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 07 /
DUAN, Maosheng GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 08 /
DEANDA, JR. Felix GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 09 /
KOBLE, Cecilia Suarez GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 10 /
MCLEAN, Ed Williams GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 11 /
PECKHAM, Jennifer Poole GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 12 /
PERKINS, Angilique C. GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 027709 / US | 13 /
THOMPSON, James Benjamin GlaxoSmithKline, Five Moore Drive, PO Box 13398 Research Triangle Park, NC 27709 / US | 14 /
VANDERWALL, Dana GlaxoSmithKline, Five Moore Drive, O Box 13398 Research Triangle Park, NC 27709 / US | [2005/36] | Representative(s) | Gladwin, Amanda Rachel GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
Former [2005/36] | Gladwin, Amanda Rachel GlaxoSmithKline, Corporate Intellectual Property, CN925.1, 980 Great West Road Brentford Middlesex TW8 9GS / GB | Application number, filing date | 03813419.3 | 12.12.2003 | [2005/36] | WO2003US39644 | Priority number, date | US20020433634P | 13.12.2002 Original published format: US 433634 P | [2005/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004054974 | Date: | 01.07.2004 | Language: | EN | [2004/27] | Type: | A2 Application without search report | No.: | EP1569646 | Date: | 07.09.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.07.2004 takes the place of the publication of the European patent application. | [2005/36] | Search report(s) | International search report - published on: | EP | 02.09.2004 | Classification | IPC: | A61K31/46, A61K31/445, C07D451/04, A61P31/18 | [2005/36] | CPC: |
C07D451/04 (EP,KR,US);
A61K31/46 (KR);
A61P31/12 (EP);
A61P31/18 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/36] | Extension states | AL | Not yet paid | LT | 06.06.2005 | LV | 06.06.2005 | MK | Not yet paid | Title | German: | PIPERIDINDERVIATEALS CCR5-ANTAGONISTEN | [2005/36] | English: | PIPERIDINE DERIVATIVES AS CCR5 ANTAGONISTS | [2005/36] | French: | ANTAGONISTES DE CCR5 UTILES COMME AGENTS THERAPEUTIQUES | [2005/36] | Entry into regional phase | 06.06.2005 | National basic fee paid | 06.06.2005 | Designation fee(s) paid | 06.06.2005 | Examination fee paid | Examination procedure | 09.06.2004 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 06.06.2005 | Examination requested [2005/36] | 11.11.2008 | Despatch of a communication from the examining division (Time limit: M06) | 11.05.2009 | Reply to a communication from the examining division | 12.10.2009 | Despatch of a communication from the examining division (Time limit: M06) | 23.04.2010 | Application deemed to be withdrawn, date of legal effect [2010/42] | 01.06.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/42] | Fees paid | Renewal fee | 05.12.2005 | Renewal fee patent year 03 | 05.12.2006 | Renewal fee patent year 04 | 05.12.2007 | Renewal fee patent year 05 | 08.12.2008 | Renewal fee patent year 06 | 07.12.2009 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO9904794 (MERCK & CO INC [US], et al) [Y] 1-61 * page 103, line 12 - line 17; claims 1,15,18,20 *; | [Y]WO0038680 (PFIZER LTD [GB], et al) [Y] 1-61 * page 27, line 10; claims 1,2,5-20 *; | [A]WO02079190 (SMITHKLINE BEECHAM PLC [GB], et al) [A] 1-61 * page 12, line 1 - line 3; claim 1; table 1 *; | [X]WO9825605 (MERCK & CO INC [US], et al) [X] 1-61 * page 61, line 5 - line 11; claims 1,11 * * page 16 - page 34 *; | [X]US5340822 (EMONDS-ALT XAVIER [FR], et al) [X] 1-23,25-28,52-54,59,60 * column 1, line 11 - line 24; examples 22-24; claim 1 *; | [X]BE601228 (JANSSEN PAUL ADRIAAN JAN) [X] 1-23,25-28,54 * page 2, line 23 - line 27; claim 1 * * page 9, line 10 - page 28, line 10 *; | [X]US2773870 (BILL ELPERN) [X] 1-23,25-28,54 * column 1, line 20 - line 61 * * examples *; | [X]US3539580 (HERMANS HUBERT KAREL FRANS, et al) [X] 1-23,25-28,54 * column 1, line 13 - line 15; claims 1,5-7 * * table *; | [X]US3334106 (BIEL JOHN H) [X] 1-23,25-28,54 * the whole document *; | [X]US2248018 (OTTO EISLEB) [X] 1,25-28,54 * column 1, line 52 - line 55; examples 3,4; claim 6 *; | [X]WO9825604 (MERCK & CO INC [US], et al) [X] 1,7-12,20,25-61 * page 30, line 26 - line 30 * * page 34, line 1 - line 22 * * page 55 - page 85; claim 1 *; | [X]JP2002348288 | [X] - REHSE K ET AL, "Platelet aggregation inhibiting and anticoagulant effects of oligoamines, 1: N-(4-piperidinyl)methanamines", ARCHIV DER PHARMAZIE, VCH VERLAGSGESELLSCHAFT MBH, WEINHEIM, DE, (1986), vol. 319, no. 319, ISSN 0365-6233, pages 505 - 515, XP001085385 [X] 1,25-28,52-54,59,60 * the whole document * DOI: http://dx.doi.org/10.1002/ardp.19863190606 | [X] - STEVENTON ET AL, "4,4-disubstituted Piperidine High-Affinity NK1 Antagonists: Structure-Activity Relationships and in Vivo Activity", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (1998), vol. 41, no. 23, ISSN 0022-2623, pages 4623 - 4622, XP002173109 [X] 1,25-28,54 * the whole document * DOI: http://dx.doi.org/10.1021/jm980376b | [X] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2003, no. 35, Database accession no. 2003-367209, XP002283279 & JP2002348288 A 20021204 (ONO PHARM CO LTD) [X] 1,7-12,20,25-61 * abstract * |